September 2014 FDA Recall Drug by Astellas Pharma Us Inc
D-0008-2015 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Astellas Pharma Us Inc on September 15, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0008-2015

Reason for Recall
Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Initiated
09-15-2014
Reported
10-15-2014
Quantity
9,236 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Astellas Pharma US Inc
Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

Batch or Lot Expiration Information

Lot# Lot 66482CW, Exp 04/16